Later-Line Infigratinib Outperforms Standard Chemotherapy in Cholangiocarcinoma
- This topic has 0 replies, 1 voice, and was last updated 3 years, 9 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Later-Line Infigratinib Outperforms Standard Chemotherapy in Cholangiocarcinoma
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.